Mavrilimumab
Mavrilimumab is a human monoclonal antibody that is designed for the treatment of rheumatoid arthritis. It is an immunoglobulin G4, anti-granulocyte macrophage colony-stimulating factor (GM-CSF) receptor α monoclonal antibody. Mavrilimumab was developed by MedImmune, a subsidiary of AstraZeneca.
Mechanism of Action[edit | edit source]
Mavrilimumab works by binding to the alpha chain of the GM-CSF receptor, inhibiting GM-CSF signaling. GM-CSF is a cytokine that plays a crucial role in inflammation and autoimmunity, including the pathogenesis of rheumatoid arthritis.
Clinical Trials[edit | edit source]
Mavrilimumab has undergone Phase IIb clinical trials for rheumatoid arthritis. The results showed that the drug was well-tolerated and led to improvements in disease activity. It is currently undergoing Phase III trials.
COVID-19 Treatment[edit | edit source]
In 2020, mavrilimumab was investigated as a potential treatment for COVID-19. Preliminary results from a small, single-center, open-label study in Italy suggested that mavrilimumab may reduce the risk of respiratory failure and death in patients with severe COVID-19 pneumonia.
See Also[edit | edit source]
References[edit | edit source]
| Mavrilimumab Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
